World Health Statistics Annual, Volume III, 1977: Health Personnel and Hospital Establishments

1978 ◽  
Vol 35 (5) ◽  
pp. 604-604
Author(s):  
2020 ◽  
Vol 10 (31) ◽  
pp. 87-95
Author(s):  
Nicole Maria Miyamoto Bettini ◽  
Fabiana Tomé Ramos ◽  
Priscila Masquetto Vieira de Almeida

A Organização Mundial da Saúde - OMS confirmou a circulação internacional do novo Coronavírus em janeiro de 2020, nomeando-o como COVID-19 e, declarando uma pandemia. É de extrema importância que durante a pandemia, os profissionais de saúde tenham acesso e conhecimento sobre o uso correto dos Equipamentos de Proteção Individual (EPIs) e suas indicações, tomando assim, as devidas precauções na prevenção de infecções. O presente estudo buscou identificar a padronização mundial quanto ao uso dos EPIs utilizados no atendimento a pacientes suspeitos e/ou confirmados de COVID-19 no Brasil, EUA, China, Espanha, Itália e demais países europeus. Os guidelines apresentam a padronização quanto ao uso dos EPIs utilizados no atendimento a suspeitos e/ou confirmados de COVID-19, indo ao encontro das recomendações fornecidas pela OMS. Até o momento, o uso de EPIs é sem dúvida a estratégia mais importante e eficaz para proteger os profissionais de saúde durante a assistência ao paciente com COVID-19.Descritores: Infecções por Coronavírus, Equipamento de Proteção Individual, Pessoal de Saúde, Enfermagem. Recommendations for personal protective equipment to combat COVID-19Abstract: The World Health Organization - WHO confirmed the international circulation of the new Coronavirus in January 2020, naming it as COVID-19 and declaring a pandemic. It is extremely important that during the pandemic, health professionals have access and knowledge about the correct use of Personal Protective Equipment (PPE) and its indications, thus taking appropriate precautions to prevent infections. The present study sought to identify the worldwide standardization regarding the use of PPE utilized to take care of suspected and confirmed patients with COVID-19 in Brazil, USA, China, Spain, Italy and other European countries. The guidelines present a standardization regarding the use of PPE utilized to take care of suspected and confirmed with COVID-19, in line with the recommendations provided by WHO. To date, the use of PPE is undoubtedly the most important and effective strategy to protect healthcare professionals during care for patients with COVID-19.Descriptors: Coronavirus Infections, Personal Protective Equipment, Health Personnel, Nursing. Recomendaciones para el equipo de protección personal para combatir COVID-19Resumen: La Organización Mundial de la Salud - La OMS confirmó la circulación internacional del nuevo Coronavirus en enero de 2020, nombrándolo COVID-19 y declarando una pandemia. Es extremadamente importante que durante la pandemia, los profesionales de la salud tengan acceso y conocimiento sobre el uso correcto del Equipo de Protección Personal (EPP) y sus indicaciones, tomando así las precauciones adecuadas para prevenir infecciones. El presente estudio buscó identificar la estandarización mundial con respecto al uso de EPP utilizado para atender a pacientes sospechosos y/o confirmados con COVID-19 en Brasil, Estados Unidos, China, España, Italia y otros países europeos. Las pautas presentan la estandarización con respecto al uso de EPP utilizado para cuidar COVID-19 sospechoso y/o confirmado, de acuerdo con las recomendaciones proporcionadas por la OMS. Hasta la fecha, el uso de EPP es, sin duda, la estrategia más importante y efectiva para proteger a los profesionales de la salud durante la atención de pacientes con COVID-19.Descriptores: Infecciones por Coronavirus, Equipo de Protección Personal, Personal de Salud, Enfermería.


2021 ◽  
Vol 16 (02) ◽  
pp. 074-079
Author(s):  
Hasan Kucukkendirci ◽  
Fatih Kara ◽  
Gulsum Gulperi Turgut

AbstractObjective According to the 2017 report of the World Health Organization (WHO), ∼1.5 million people die from vaccine preventable diseases. The WHO is working to generate and popularize effective vaccination programs. However, the concept of “vaccine rejection,” which first started in Europe and United States, has started to make an impact in Turkey during the past 10 years. It is therefore seen as a growing danger in future. This study was conducted to determine, detect, and prevent the reasons of vaccine rejection that have increased in recent years.Methods A cross-sectional study was conducted between June and December at 2015. In all districts of Konya (n = 31), it was aimed to reach all 242 families who rejected vaccination to their 0 to 2 years old babies. Families having more than one child refused to vaccinate all of their children. A questionnaire consisting of 47 questions was prepared by the researchers, using the standard trainings of the Ministry of Health and the literature. A total of 172 families agreed to participate in this study. The questionnaire was applied to the parents using the telephone interview technique. Data were presented as mean ± standard deviation and percentage.Results About 41.3% (n = 71) of the mothers were high school graduates, 50.6% (n = 87) of their fathers were university graduates. About 82.6% (n = 142) of the participants received examination, treatment and follow-up services from family physicians and family health personnel. About 20.9% (n = 36) of the children were the only children of the family. About 55.8% (n = 96) of the families also refused the vaccination for other children. About 83.7% (n = 144) of the unvaccinated children had infants/children follow-up care. While all participants stated that vaccines had side effects, 31.4% (n = 54) of these believed that vaccines cause autism or paralysis in infants. About 62.2% (n = 107) of their mothers did not receive tetanus vaccine during pregnancy. The highest rate of nonvaccination was with the second dose of hepatitis A vaccine, which 96.5% (n = 166) refused. The most accepted vaccine was the first dose of hepatitis B vaccine, which was refused by 18.0% (n = 31). About 79.7% (n = 137) of the participants did not know the reason for the vaccination and 95.9% (n = 165) thought that the vaccines were not required. All participants received information from the health personnel about the vaccines. While 9.9% (n = 17) of the families thought that vaccines cause infertility, 44.8% (n = 77) did not receive vaccination because the vaccines were produced abroad.Conclusion A growing number of families refuse to have their babies vaccinated. The production of vaccines abroad is a major cause of insecurity. There are also beliefs that vaccines cause infertility. Vaccine production in Turkey should be accelerated and public education about vaccines should be reviewed. Training provided to families about vaccines should also be reviewed.


2003 ◽  
Vol 7 (6) ◽  
Author(s):  

The European health for all database provides easy and rapid access to a wide range of basic health statistics (indicators) for the 51 Member States of the World Health Organization (WHO) European Region. It was developed by the WHO Regional Office for Europe in the mid 1980s to support the monitoring of health trends in the Region. The database is a helpful tool for international comparison and for assessing the health situation and trends in any European country in an international context.


2013 ◽  
Vol 26 (1) ◽  
pp. 17-26 ◽  
Author(s):  
Maria da Graça Mouchrek Jaldin ◽  
Feliciana Santos Pinheiro ◽  
Alcione Miranda dos Santos ◽  
Nivaldo Costa Muniz

OBJETIVO: Este trabalho teve como objetivo analisar o crescimento de crianças em regime de aleitamento materno exclusivo até o sexto mês, bem como comparar seu peso e comprimento com a referência do National Center for Health Statistics 1978 e com o padrão da World Health Organization 2006. MÉTODOS: Trata-se de estudo longitudinal realizado em um Banco de Leite Humano, na cidade de São Luís, Maranhão, entre outubro de 2007 e novembro de 2008. Foi feita amostragem não probabilística com 328 crianças nascidas a termo e submetidas a aleitamento materno exclusivo. Finalizaram o estudo 181 crianças. Avaliou-se o crescimento por meio de médias e desvio-padrão, comparando-se os resultados com aqueles dois parâmetros. RESULTADOS: Os meninos mostraram-se mais pesados que as meninas, do primeiro ao sexto mês (p<0,05). A maior velocidade no ganho ponderal ocorreu nos dois primeiros meses de vida, em ambos os sexos. Quanto ao peso, as meninas apresentaram peso médio superior ao padrão da World Health Organization 2006, ao nascer e do terceiro ao sexto mês (p<0,05), enquanto os meninos mostraram peso superior do quarto ao sexto mês (p<0.05). Já em relação à referência do National Center for Health Statistics 1978, ambos os sexos apresentaram peso superior desde o nascimento até o sexto mês (p<0,05), exceto os meninos ao nascer. Quanto ao tamanho, as meninas apresentaram comprimento médio semelhante ao padrão da World Health Organization 2006, porém menor do que a outra referência, ao nascer e no sexto mês (p<0,05). Já os meninos obtiveram comprimento médio inferior, tanto quando comparados ao padrão da World Health Organization 2006, do nascimento ao sexto mês (p<0,05), exceto o quinto; como quando comparados à referência da National Center for Health Statistics 1978, ao nascer e no primeiro, no quarto e no sexto meses de vida (p<0,05). CONCLUSÃO: O crescimento ponderal das crianças em aleitamento materno exclusivo assemelhou-se mais ao padrão World Health Organization 2006 que à referência National Center for Health Statistics 1978, ao passo que o crescimento linear mostrou-se compatível com os dois parâmetros.


Sign in / Sign up

Export Citation Format

Share Document